EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Changes in pneumococcal vaccine coverage in the Canadian Longitudinal Study on Aging (CLSA): An analysis based on the 2018–2021 follow-up 2 survey

Giorgia Sulis iD, Nawal Maredia, Christina Wolfson, Nicole E Basta

PLOS One · 2026

DOI: 10.1371/journal.pone.0338213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Giorgia Sulis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Pneumococcal Vaccines, Pneumococcal Infections, Vaccination Coverage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canada Research Chairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pneumococcal vaccination is recommended for older adults and individuals with chronic medical conditions (CMC) due to the high risk of invasive pneumococcal disease in these groups. Despite this, vaccination coverage in Canada remains below the national target of 80%, to be achieved by 2025. We conducted a new analysis of recently released data from the Canadian Longitudinal Study on Aging (CLSA), aimed at providing estimates of pneumococcal vaccine coverage from 2018–2021 among eligible adults, identifying sociodemographic disparities, and exploring changes over time since 2015.

Methods

The CLSA, a nationally representative cohort launched in 2011, recently released data collected during the second follow-up visit (FUP2; 2018–2021). We conducted a cross-sectional analysis of participant self-reported pneumococcal vaccination status, stratified by sociodemographic characteristics, receipt of influenza vaccine in the previous 12 months, and contact with family doctor in the previous 12 months. Logistic regression was used to identify factors associated with being newly vaccinated for pneumococcal disease as reported during FUP2 compared with three years earlier during follow-up 1 (FUP1; 2015–2018). We previously reported pneumococcal vaccination estimates for 2015–2018.

Results

Only 56.8% (95% CI: 55.8–57.7%; n = 10,530) of eligible study participants aged 65 years and older and 19.3% (95% CI: 18.1–20.5%; n = 4,055) of those aged

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumococcal VaccinesPneumococcal InfectionsVaccination CoverageHumansCanadian Longitudinal Study on AgingMaleCanadaAgedFemaleMiddle AgedCross-Sectional StudiesFollow-Up StudiesVaccinationLongitudinal StudiesAged, 80 and over

Substanzen

Pneumococcal Vaccines

Autor:innen und Institutionen

  • Faculty of Medicine, School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
  • Methodological and Implementation Research Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Department of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.
  • Neuroepidemiology Research Unit, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

ORCID-Profile: Giorgia Sulis

Förderung

  • Canada Research Chairs

Zitieren

APA

Sulis, G., Maredia, N., Wolfson, C., & Basta, N. E. (2026). Changes in pneumococcal vaccine coverage in the Canadian Longitudinal Study on Aging (CLSA): An analysis based on the 2018–2021 follow-up 2 survey. PLOS One. https://doi.org/10.1371/journal.pone.0338213

Vancouver

Sulis G, Maredia N, Wolfson C, Basta NE. Changes in pneumococcal vaccine coverage in the Canadian Longitudinal Study on Aging (CLSA): An analysis based on the 2018–2021 follow-up 2 survey. PLOS One. 2026. doi:10.1371/journal.pone.0338213

BibTeX
@article{Sulis2026,
  author = {Sulis, Giorgia and Maredia, Nawal and Wolfson, Christina and Basta, Nicole E},
  title = {Changes in pneumococcal vaccine coverage in the Canadian Longitudinal Study on Aging (CLSA): An analysis based on the 2018–2021 follow-up 2 survey},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0338213}
}
Kostenlos starten →